A protein standard addition framework for absolute quantification of drug metabolizing enzymes
Drug Metabolism and Disposition · 2026-08 · 54 (8) · 100347
DOI: 10.1016/j.dmd.2026.100347 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-08. Verfasst von Xiaofeng Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc., Groton, Connecticut. Electronic address: Xiaofeng.Wu2@pfizer.com. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP3A, Microsomes, Liver, Proteomics. Die Arbeit nennt 19 Literaturangaben. Gefördert von: Pfizer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc., Groton, Connecticut. Electronic address: Xiaofeng.Wu2@pfizer.com.
- Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc., Groton, Connecticut.
- Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc., Groton, Connecticut. Electronic address: lloydweitat.tang@pfizer.com.
Förderung
- Pfizer
Zitieren
APA
Wu, X., Zhang, S., Obach, R. S., Yuan, Q., Lapham, K., Shi, Y., & Tang, L. W. T. (2026). A protein standard addition framework for absolute quantification of drug metabolizing enzymes. Drug Metabolism and Disposition, 54(8), 100347. https://doi.org/10.1016/j.dmd.2026.100347
Vancouver
Wu X, Zhang S, Obach RS, Yuan Q, Lapham K, Shi Y, et al. A protein standard addition framework for absolute quantification of drug metabolizing enzymes. Drug Metabolism and Disposition. 2026;54(8):100347. doi:10.1016/j.dmd.2026.100347
BibTeX
@article{Wu2026,
author = {Wu, Xiaofeng and Zhang, Sam and Obach, R Scott and Yuan, Qianying and Lapham, Kimberly and Shi, Yuanyuan and Tang, Lloyd Wei Tat},
title = {A protein standard addition framework for absolute quantification of drug metabolizing enzymes},
journal = {Drug Metabolism and Disposition},
year = {2026},
volume = {54},
number = {8},
pages = {100347},
doi = {10.1016/j.dmd.2026.100347}
}
EUVIMED